Puylaert Kevin sold SOPH
April 6, 2026 · Form 4 insider transaction
Puylaert Kevin sold 46 shares of SOPHiA GENETICS SA at $4.86 per share, a transaction worth $223.56. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
46
Price
$4.86
Total value
$223.56
InsiderPuylaert Kevin
Role—
CompanySOPHiA GENETICS SA (SOPH)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateApril 6, 2026
Filing dateApril 8, 2026
Shares owned after148,260
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on April 2, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades.